Neurogene

Develops genetic medicines for rare neurological diseases.

BiotechnologyPharmaceuticals neurogene.com ↗

Company facts

Founded
2018
Employees
131
Headquarters
United States
Type
Public
Listed
NASDAQ: NGNE